FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Jul 30, 2025
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on July 30, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6570e94b-363d-42f6-b472-573b8d2c94c3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1282260
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2024 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| November 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| August 18, 2017 | Not classified | New York District Office | |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1250019 - 2024-09-09
- FDA Inspection 1110911 - 2019-11-25
- FDA Inspection 1042701 - 2018-02-23
- FDA Inspection 1042383 - 2017-08-18
- FDA Inspection 1007875 - 2017-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.